Quantinno Capital Management LP acquired a new stake in Nutex Health Inc. (NASDAQ:NUTX – Free Report) during the 1st quarter, HoldingsChannel reports. The firm acquired 8,875 shares of the company’s stock, valued at approximately $843,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Islay Capital Management LLC purchased a new stake in Nutex Health in the fourth quarter worth $34,000. BNP Paribas Financial Markets lifted its position in shares of Nutex Health by 966.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after buying an additional 290 shares during the last quarter. Royal Bank of Canada lifted its position in shares of Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after buying an additional 316 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after acquiring an additional 2,043 shares during the period. Finally, Vestcor Inc bought a new position in shares of Nutex Health during the 3rd quarter worth $111,000. 5.32% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
NUTX has been the subject of several recent research reports. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Lake Street Capital reiterated a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. B. Riley Financial assumed coverage on shares of Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 target price for the company. Zacks Research upgraded shares of Nutex Health to a “hold” rating in a research note on Monday, June 29th. Finally, Wall Street Zen downgraded shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $268.33.
Nutex Health Price Performance
Shares of Nutex Health stock opened at $188.41 on Tuesday. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $1.29 billion, a PE ratio of 7.40 and a beta of 0.24. The business’s 50-day moving average price is $163.45 and its 200-day moving average price is $130.23. Nutex Health Inc. has a 12 month low of $77.21 and a 12 month high of $204.00.
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. Sell-side analysts forecast that Nutex Health Inc. will post 30.11 EPS for the current fiscal year.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Featured Stories
- Five stocks we like better than Nutex Health
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTX – Free Report).
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
